Screener

Operating Income (Loss)

Name: Recursion Pharmaceuticals, Inc. Operating Income (Loss) by Business Segments
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Recursion Pharmaceuticals, Inc.·Business Segments·1 segment·Rolls up to Operating Income

Breakdown

Segment	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26	Q2 '26
Business Segments	-$191.37M	-$176.23M	-$172.2M	-$108.33M	-$128.51M	-$134.97M
Total	-$191.37M	-$176.23M	-$172.2M	-$108.33M	-$128.51M	-$134.97M

Segments

Business SegmentsView metric